期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

形态学检查在骨髓增生异常综合征中的诊断价值

Diagnostic value of the morphological examination in myelodysplastic syndrome
下载PDF
导出
摘要 目的:本文探讨病态造血在研究骨髓增生异常综合症(MDS)中的诊断价值。方法:收集确诊MDS患者153例,非克隆性血细胞减少对照组164例,进行骨髓细胞学分析。结果:MDS患者粒系、红系、巨核等病态造血发生率与对照组差别有统计学意义(P<0.05)。结论:病态造血在MDS诊断中具有重要意义。 Objective： To explore the role of dyshaematopoiesis in diagnosis of patients with myelodysplastic syndrome（MDS）.Methods： The clinical data of 153 patients with MDS and 164 control group with nonclone hypocytosis were investigated by bone marrow cytomorphologic examination.Results： Dyshaematopoiesis has high incidence rate in myelodysplastic syndrome.Conclusion： Dyshaematopoiesis was useful for diagnosis in MDS.
作者 刘会敏 谢辉 刘旭华
机构地区 郑州人民医院检验科
出处 《河南医学研究》 CAS 2012年第3期332-333,336,共3页 Henan Medical Research
关键词 骨髓增殖异常综合症 病态造血 诊断价值 myelodysplastic syndrome dyshaematopoiesis diagnostic value
分类号 R446 [医药卫生—诊断学]
  • 相关文献

参考文献8

  • 1张之南,沈悌.血液病诊断及疗效标准[M].第3版.北京:科学出版社,2003:157-163.
  • 2刘丹丹,吴德沛.细胞形态学检查诊断骨髓增生异常综合征临床意义[J].中国实用内科杂志,2010,30(5):398-401. 被引量：20
  • 3Vardiman J M.Hematopathological concepts and contronersies in thediagnosis and classification of myelodysplastic syndromes[J].Hema-tology Am Soc Hematol Educ Prpgram,2006,72(7):199-204.
  • 4Haus O,kotlarek-Haus S,Potoczek S,et al.Myelodysplastic syndromesaccording to FAB and WHO classification.single center expericnce[J].Neoplasma,2006,53(5):136-143.
  • 5Hamblin T.Minimal,diagnostic criteria for the mgelodysplastic syn-drome in clinical practice[J].leuk Res,1992,16(3):3.
  • 6徐娟,郭轶先,赵弘,惠吴函,万岁桂,孙雪静.骨髓增生异常综合征患者细胞免疫表型异常[J].中国实验血液学杂志,2009,17(4):894-897. 被引量：6
  • 7Matsui W H,Brodsky R A,Smith B D,et al.Quantitative analysis ofbone marrow CD34 cells in aplastic anemia and hypoplastic myelodys-plastic syndromes[J].Leukemia,2006,20(5):458-462.
  • 8Ogata K,Kishikawa Y,Satoh C,et al.Diagnostic application of flowcytometric characteristics of CD34+cells in low-grade myelodysplasticsyndromes[J].Blood,2006,108(13):1037-1044.

二级参考文献20

  • 1Heaney ML, Gold DW. Myelodysplasia. N Engl J Med, 1999; 340 : 1649 - 1660.
  • 2Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatdment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res, 2007 ;31:727 -736.
  • 3Nimer SD. Myelodysplastic Syndromes. Blood, 2008 ; 111 : 4841 -4851.
  • 4Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelo- dysplastic syndrome correlates with the IPSS and with the outcome after hematopoietic stem cell transplantation. Blood, 2003;102:394 - 403.
  • 5Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 2002 ; 100:2292 - 2302.
  • 6Jaffe ES, Harris NL, Stein H, et al. Tumours of Haematopoietic and Lymphoid Tissues. In: World Health Organization Classification of Tumours. Lyon, France: IARC Press. 2001:60-73.
  • 7Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 1997 ; 89 : 2097 -2088.
  • 8Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood, 2008 ; 111 : 3941 - 3967.
  • 9Maynadie M, Picard F, Husson B, et al. Immunophenotypic clustering of myelodysplastic syndromes. Blood, 2002; 100:2349 - 2356.
  • 10Olaru D, Campos L, Flandrin P, et al. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immnnophenotypes. Cytometry B, Clin Cytom, 2008 ;74 : 17 - 24.

共引文献22

河南医学研究
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部